A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: rucaparib
Sponsor: UNICANCER
Collaborators: Clovis Oncology, Inc.|Fondation ARC